CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Site Search
Showing 1 - 5 of 5 results
Press Release
|
Feb. 22, 2010
|
4 min read
Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.
Press Release
|
June 16, 2021
|
2 min read
Today, the Cystic Fibrosis Foundation announced it has awarded up to $3.3 million to Polyphor AG to develop an inhaled version of murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in people with cystic fibrosis. About 17% of individuals with CF who had Pseudomonas infections last year had multi-drug resistant strains.
Press Release
|
Nov. 24, 2020
|
3 min read
Men and women with CF can have biological kids, but fertility has not always been priorities of CF care. As people with CF live longer, healthier lives than before, more men and women must make crucial decisions about their reproductive health.
Although CF may have consequences for your reproductive health, it does not diminish sexual performance or the desire for intimacy. People with CF may worry about experiencing shortness of breath, coughing or hemoptysis (coughing up blood or blood-stained mucus), but these problems should not keep them from enjoying a normal, fulfilling sex life.